Concepts (48)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Septal Defects, Ventricular | 1 | 2023 | 133 | 0.180 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2021 | 98 | 0.170 |
Why?
|
| Software | 1 | 2024 | 752 | 0.150 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2023 | 283 | 0.150 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 132 | 0.150 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 698 | 0.150 |
Why?
|
| Bone Marrow | 1 | 2020 | 314 | 0.140 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2021 | 152 | 0.140 |
Why?
|
| Transcriptome | 1 | 2024 | 1150 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2020 | 216 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 580 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 578 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 1811 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 849 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1788 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1899 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1835 | 0.060 |
Why?
|
| SOXF Transcription Factors | 1 | 2023 | 18 | 0.050 |
Why?
|
| Endocardium | 1 | 2023 | 47 | 0.050 |
Why?
|
| Inflammation | 2 | 2021 | 1493 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2023 | 130 | 0.050 |
Why?
|
| Oncogenes | 1 | 2021 | 164 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2020 | 133 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 872 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 138 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 528 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 675 | 0.040 |
Why?
|
| Myocardium | 1 | 2023 | 874 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 344 | 0.030 |
Why?
|
| Mitochondria | 1 | 2023 | 761 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 364 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 18479 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 3694 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 764 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1010 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2993 | 0.030 |
Why?
|
| Humans | 5 | 2024 | 131781 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3451 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 34402 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1542 | 0.020 |
Why?
|
| Neoplasms | 1 | 2024 | 2963 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10965 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 13324 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 15057 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 20994 | 0.010 |
Why?
|
| Child | 1 | 2020 | 26316 | 0.010 |
Why?
|
| Male | 1 | 2020 | 65290 | 0.010 |
Why?
|
| Female | 1 | 2020 | 71221 | 0.010 |
Why?
|